These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
382 related items for PubMed ID: 10782754
1. Effects of acarbose treatment in Type 2 diabetic patients under dietary training: a multicentre, double-blind, placebo-controlled, 2-year study. Hasche H, Mertes G, Bruns C, Englert R, Genthner P, Heim D, Heyen P, Mahla G, Schmidt C, Schulze-Schleppinghof B, Steger-Johannsen G. Diabetes Nutr Metab; 1999 Aug; 12(4):277-85. PubMed ID: 10782754 [Abstract] [Full Text] [Related]
2. Comparison of acarbose and metformin in patients with Type 2 diabetes mellitus insufficiently controlled with diet and sulphonylureas: a randomized, placebo-controlled study. Willms B, Ruge D. Diabet Med; 1999 Sep; 16(9):755-61. PubMed ID: 10510952 [Abstract] [Full Text] [Related]
3. Efficacy and safety of acarbose add-on therapy in the treatment of overweight patients with Type 2 diabetes inadequately controlled with metformin: a double-blind, placebo-controlled study. Halimi S, Le Berre MA, Grangé V. Diabetes Res Clin Pract; 2000 Sep; 50(1):49-56. PubMed ID: 10936668 [Abstract] [Full Text] [Related]
4. Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study. Coniff RF, Shapiro JA, Robbins D, Kleinfield R, Seaton TB, Beisswenger P, McGill JB. Diabetes Care; 1995 Jun; 18(6):817-24. PubMed ID: 7555508 [Abstract] [Full Text] [Related]
5. Efficacy and tolerability of acarbose in Asian patients with type 2 diabetes inadequately controlled with diet and sulfonylureas. Lin BJ, Wu HP, Huang HS, Juang JH, Sison A, bin Abdul Kadir DK, Cho CG, Sridama W, Writing Group for the Asian Study of Acarbose with Sulfonylureas. J Diabetes Complications; 2003 Jun; 17(4):179-85. PubMed ID: 12810240 [Abstract] [Full Text] [Related]
6. Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy. Standl E, Baumgartl HJ, Füchtenbusch M, Stemplinger J. Diabetes Obes Metab; 1999 Jul; 1(4):215-20. PubMed ID: 11228756 [Abstract] [Full Text] [Related]
7. Acarbose improves glycemic control in overweight type 2 diabetic patients insufficiently treated with metformin. Phillips P, Karrasch J, Scott R, Wilson D, Moses R. Diabetes Care; 2003 Feb; 26(2):269-73. PubMed ID: 12547847 [Abstract] [Full Text] [Related]
8. Efficacy and safety of acarbose in insulin-treated patients with type 2 diabetes. Kelley DE, Bidot P, Freedman Z, Haag B, Podlecki D, Rendell M, Schimel D, Weiss S, Taylor T, Krol A, Magner J. Diabetes Care; 1998 Dec; 21(12):2056-61. PubMed ID: 9839094 [Abstract] [Full Text] [Related]
9. Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes. Rosenstock J, Brown A, Fischer J, Jain A, Littlejohn T, Nadeau D, Sussman A, Taylor T, Krol A, Magner J. Diabetes Care; 1998 Dec; 21(12):2050-5. PubMed ID: 9839093 [Abstract] [Full Text] [Related]
10. Acarbose treatment does not change the habitual diet of patients with Type 2 diabetes mellitus. The Finnish Acargbos Study Group. Lindström J, Tuomilehto J, Spengler M. Diabet Med; 2000 Jan; 17(1):20-5. PubMed ID: 10691155 [Abstract] [Full Text] [Related]
11. Acarbose and metabolic control in patients with type 2 diabetes with newly initiated insulin therapy. Schnell O, Mertes G, Standl E, Acarbose-Insulin Combination Study Group. Diabetes Obes Metab; 2007 Nov; 9(6):853-8. PubMed ID: 17924867 [Abstract] [Full Text] [Related]
12. An Asian multicenter clinical trial to assess the efficacy and tolerability of acarbose compared with placebo in type 2 diabetic patients previously treated with diet. Asian Acarbose Study Group. Chan JC, Chan KW, Ho LL, Fuh MM, Horn LC, Sheaves R, Panelo AA, Kim DK, Embong M. Diabetes Care; 1998 Jul; 21(7):1058-61. PubMed ID: 9653595 [Abstract] [Full Text] [Related]
13. A double-blind placebo-controlled trial evaluating the safety and efficacy of acarbose for the treatment of patients with insulin-requiring type II diabetes. Coniff RF, Shapiro JA, Seaton TB, Hoogwerf BJ, Hunt JA. Diabetes Care; 1995 Jul; 18(7):928-32. PubMed ID: 7555551 [Abstract] [Full Text] [Related]
14. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44). Holman RR, Cull CA, Turner RC. Diabetes Care; 1999 Jun; 22(6):960-4. PubMed ID: 10372249 [Abstract] [Full Text] [Related]
15. Acarbose improves glycemic control in insulin-treated Asian type 2 diabetic patients: results from a multinational, placebo-controlled study. Hwu CM, Ho LT, Fuh MM, Siu SC, Sutanegara D, Piliang S, Chan JC, Asian Acarbose Study Group. Diabetes Res Clin Pract; 2003 May; 60(2):111-8. PubMed ID: 12706319 [Abstract] [Full Text] [Related]
16. Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study. Hoffmann J, Spengler M. Diabetes Care; 1994 Jun; 17(6):561-6. PubMed ID: 8082525 [Abstract] [Full Text] [Related]
17. Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study. Hoffmann J, Spengler M. Am J Med; 1997 Dec; 103(6):483-90. PubMed ID: 9428831 [Abstract] [Full Text] [Related]
18. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial. Derosa G, Franzetti I, Querci F, D'Angelo A, Maffioli P. Pharmacotherapy; 2015 Nov; 35(11):983-90. PubMed ID: 26598090 [Abstract] [Full Text] [Related]
19. Acarbose in NIDDM patients with poor control on conventional oral agents. A 24-week placebo-controlled study. Lam KS, Tiu SC, Tsang MW, Ip TP, Tam SC. Diabetes Care; 1998 Jul; 21(7):1154-8. PubMed ID: 9653611 [Abstract] [Full Text] [Related]
20. Effect of acarbose on insulin sensitivity in elderly patients with diabetes. Meneilly GS, Ryan EA, Radziuk J, Lau DC, Yale JF, Morais J, Chiasson JL, Rabasa-Lhoret R, Maheux P, Tessier D, Wolever T, Josse RG, Elahi D. Diabetes Care; 2000 Aug; 23(8):1162-7. PubMed ID: 10937515 [Abstract] [Full Text] [Related] Page: [Next] [New Search]